Enhanced Intraocular Physiological Sensors for Glaucoma Management

The inventive concept discloses a suite of improvements to intraocular physiological sensors, enabling continuous monitoring, personalized treatment, and enhanced safety features for glaucoma patients.

The original patent, 'Intraocular physiological sensor', provided a foundational approach to measuring intraocular pressure. However, it had limitations in terms of continuous monitoring, personalized treatment, and sensor maintenance. The new inventive concept addresses these limitations by introducing advanced features, such as multi-point pressure measurement, self-cleaning mechanisms, and real-time data transmission.

The inventive concept comprises multiple components: (1) an implantable intraocular sensor with a self-cleaning mechanism, ensuring accurate measurements over time; (2) a data processing unit that calculates pressure gradients across the eye; (3) a system for personalized glaucoma management, utilizing machine learning algorithms to analyze pressure data and provide tailored treatment recommendations; and (4) a real-time intraocular pressure monitoring system, alerting patients and healthcare providers of abnormal readings. These advancements enable more effective glaucoma diagnosis, monitoring, and treatment.

The new inventive concept introduces several novel features, including the self-cleaning mechanism, pressure gradient calculation, and personalized treatment recommendations. These innovations provide a significant improvement over the original patent, offering enhanced safety, accuracy, and personalized care for glaucoma patients.

Alternative embodiments of the inventive concept could include variations in sensor design, data processing algorithms, and notification systems. For example, the sensor could be miniaturized for easier implantation, or the data processing unit could utilize artificial intelligence to identify patterns indicative of glaucoma. Additionally, the notification system could be integrated with existing healthcare infrastructure to facilitate seamless communication between patients and healthcare providers.

The enhanced intraocular physiological sensors have significant commercial potential in the ophthalmology and healthcare industries. They could be marketed as a premium product for glaucoma patients, offering improved monitoring and treatment outcomes. The sensors could also be integrated into existing healthcare systems, providing a new revenue stream for healthcare providers and manufacturers.